Medicines
Find medicines for human use by name or active substance.
Browse by initial
Medicines beginning with T
681–700 of 1,317 medicines
-
-
-
THYROZOL 5mg film-coated tablets MERCK SHARP DOHME
Active substance: thiamazole
Indicated for: hyperthyroidism
-
TIAPRIDA PHARMAGEN 100mg tablets
Active substance: tiapride
N05AL03 Nervous system | Antipsychotics | Benzamides
Indicated for: behavioral disorders; movement disorders
-
TIAPRIDA PMCS 100mg tablets PRO. MED. CS PRAHA
Active substance: tiapride
N05AL03 Nervous system | Antipsychotics | Benzamides
Indicated for: behavioral disorders; movement disorders
-
TIAPRIDAL 100mg tablets NEURAXPHARM ARZNEIMI
Active substance: tiapride
N05AL03 Nervous system | Antipsychotics | Benzamides
Indicated for: behavioral disorders; movement disorders
-
TIAPRIDAL 100mg/2ml solution for injection AVENTIS
Active substance: tiapride
N05AL03 Nervous system | Antipsychotics | Benzamides
Indicated for: behavioral disorders; movement disorders
-
TIAVELLA 300mg film-coated tablets G.L. PHARMA GMBH
Active substance: benfotiamine
Indicated for: vitamin B1 deficiency
-
TIAVELLA 50mg film-coated tablets G.L. PHARMA GMBH
Active substance: benfotiamine
Indicated for: vitamin B1 deficiency
-
TIBERAL 500mg film-coated tablets ROCHE
Active substance: ornidazole
J01XD03 Antiinfectives for systemic use | Other antibacterials | Imidazole derivatives
Indicated for: bacterial and protozoal infections
-
TIBSOVO 250mg film-coated tablets SERVIER
Active substance: ivosidenib
Indicated for: hematologic malignancies
-
TICAGRELOR GEMAX PHARMA 60mg film-coated tablets
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR GEMAX PHARMA 90mg film-coated tablets
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR MSN 60mg film-coated tablets MSN LABS EUROPE LIMI
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR MSN 90mg film-coated tablets MSN LABS EUROPE LIMI
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR STADA 90mg film-coated tablets
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR SWYSSI 60mg film-coated tablets SWYSSI AG
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR SWYSSI 90mg film-coated tablets SWYSSI AG
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR TERAPIA 60mg film-coated tablets
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
-
TICAGRELOR TERAPIA 90mg film-coated tablets
Active substance: ticagrelor
Indicated for: prevention of atherothrombotic events
About medicines
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.